These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 21113841

  • 1. Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria.
    Liu J, Zhao Z, Willcox MD, Xu B, Shi B.
    J Immunoassay Immunochem; 2010; 31(4):279-89. PubMed ID: 21113841
    [Abstract] [Full Text] [Related]

  • 2. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 3. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P, Chan SP.
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [Abstract] [Full Text] [Related]

  • 4. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 5. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N, Hara H, Egusa G, Yamakido M.
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [Abstract] [Full Text] [Related]

  • 6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 8. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1.
    Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, Huygen FJ, van der Meijden P, Hop WC, Hooijkaas H, Zijlstra FJ.
    Mediators Inflamm; 2006 Feb; 2006(1):28398. PubMed ID: 16864900
    [Abstract] [Full Text] [Related]

  • 9. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH.
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [Abstract] [Full Text] [Related]

  • 10. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I, Hirayama T, Shiiki H, Kanauchi M, Dohi K.
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [Abstract] [Full Text] [Related]

  • 12. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
    Tan Y, Yang Y, Zhang Z, Zhang X, Zhang Z, Liu Y.
    Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
    [Abstract] [Full Text] [Related]

  • 13. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M, Gross JL, Silveiro SP.
    J Diabetes Complications; 2006 Mar; 20(4):210-5. PubMed ID: 16798471
    [Abstract] [Full Text] [Related]

  • 14. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
    Liu BC, Zhang L, Lv LL, Wang YL, Liu DG, Zhang XL.
    Am J Nephrol; 2006 Mar; 26(5):483-90. PubMed ID: 17095863
    [Abstract] [Full Text] [Related]

  • 15. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Mar; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 16. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients.
    Hosoba M, Fujita H, Miura T, Morii T, Shimotomai T, Koshimura J, Yamada Y, Ito S, Narita T.
    Horm Metab Res; 2009 Dec; 41(12):910-5. PubMed ID: 19670106
    [Abstract] [Full Text] [Related]

  • 17. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.